<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Absence of laminin alpha2 chain leads to a severe form of <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e>) associated with <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Hence, future therapies should be aimed at alleviating both muscle and neurological dysfunctions </plain></SENT>
<SENT sid="2" pm="."><plain>Pre-clinical studies in animal models have mainly focused on ameliorating the <z:mp ids='MP_0005369'>muscle phenotype</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we show that transgenic expression of laminin alpha1 chain in muscles and the peripheral <z:mp ids='MP_0008912'>nervous</z:mp> system of laminin alpha2 chain deficient mice reduced <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> and largely corrected the peripheral nerve defects </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of laminin alpha1 chain in the peripheral <z:mp ids='MP_0008912'>nervous</z:mp> system resulted in near-<z:mpath ids='MPATH_458'>normal</z:mpath> myelination, restored Schwann cell basement membranes and improved rotarod performance </plain></SENT>
<SENT sid="5" pm="."><plain>In summary, we postulate that laminin alpha1 chain is an excellent substitute for laminin alpha2 chain in multiple tissues and suggest that treatment with laminin alpha1 chain may be beneficial for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> in humans </plain></SENT>
</text></document>